Table of Contents
- Executive Summary
- Strategic Considerations
- Stakeholder Implications
- Changing Patterns of Pharmaceutical Distribution
- Motives for Adopting Direct Distribution
- Pfi zer Rebuffed in Germany and Spain
- Pfi zer Implements Direct Distribution in the United Kingdom
- Other Manufacturers Interested in Changing Their Distribution Systems
- Investigation of U.K. Pharmaceutical Distribution
- Wholesalers' Response
- Pharmacists' Response
- Other Stakeholders' Responses
- Government View
- Outlook and Implications for the Pharmaceutical and Wholesale Industries
Table:
- 1. Discounts Offered to Pfi zer' s Direct Distribution Pharmacy Customers
in the United Kingdom
Figure:
- 1. Timetable of Key Events in the Development of Direct-to-Pharmacy
Distribution in the United Kingdom
Sidebars:
- Glaxo' s Approach to Agency Distribution
- Single-Channel Distribution in Finland and Sweden
- Logistics Service Providers: New Competition for Traditional Wholesalers
|
Related Report
|
View Cart
